(Q44491123)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

M Baryalei

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D Zenker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B Pieske

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Tondo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Dalichau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

1539-1542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report--1999

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

The long-term course of cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

Conversion from azathioprine [correction of azathioprina] to mycophenolate mofetil in pediatric renal transplant recipients with chronic rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

Introduction of mycophenolate mofetil and cyclosporine withdrawal in heart transplant patients with progressive deteriorating renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900360-9

7 January 2021

10.1016/S0041-1345(03)00360-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12826215%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference